Taylor Morrison officer disposes entire reported stake of 4,412 shares

Rhea-AI Filing Summary

Taylor Morrison Home Corp insider Todd Merrill reported a sale of 4,412 shares of TMHC common stock on 09/12/2025 at a price of $70.04 per share. The Form 4 shows 0 shares beneficially owned by the reporting person following the transaction. The filing is signed and dated 09/15/2025.

Positive

• None.

Negative

• Officer disposed of all reported holdings: 4,412 shares sold, leaving 0 shares beneficially owned after the transaction
• Concentration of transaction: Single sale of full reported position on 09/12/2025 at $70.04 per share

Insights

Financial Analyst

TL;DR: An officer sold all reported holdings (4,412 shares) at $70.04, reducing beneficial ownership to zero; financial impact is limited without additional context.

The Form 4 documents a single non-derivative sale by an executive on 09/12/2025 for 4,412 shares at $70.04, leaving the reporting person with zero beneficial ownership. As a standalone disclosure, the transaction provides clear, verifiable insider activity but does not include timing rationale or linkage to company events. Without additional transactions, aggregate holdings, or firm-level material events, this sale alone has limited direct implications for Taylor Morrison's fundamentals.

Corporate Governance Expert

TL;DR: Officer disclosed a complete disposition of reported shares; raises governance disclosure interest but no evidence of policy breach in this filing.

The filing indicates compliance with Section 16 reporting requirements: the sale is recorded with transaction date, price, and a signed filing date. The reduction to zero beneficial ownership is noteworthy from a governance monitoring perspective because it changes an insider's stake, but the Form 4 does not indicate any prohibited transactions, pledging, or plan-driven sale language. Further governance assessment would require more information on holding policies or subsequent filings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Merrill Stevin Todd

(Last) (First) (Middle)

4900 N. SCOTTSDALE ROAD, SUITE 2000

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Taylor Morrison Home Corp [ TMHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLO & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2025		S		4,412	D	$70.04	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Todd Merrill	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Todd Merrill report on Form 4 for TMHC?

The filing reports a sale of 4,412 shares of Taylor Morrison Home Corp common stock on 09/12/2025 at a price of $70.04 per share.

How many TMHC shares does the reporting person own after the reported transaction?

The Form 4 shows 0 shares beneficially owned by the reporting person following the reported sale.

When was the Form 4 signed and filed for this TMHC transaction?

The Form 4 is signed by the reporting person on 09/15/2025 and reports the transaction date as 09/12/2025.

Was the transaction in Table II (derivatives) or Table I (non-derivative)?

The disclosed sale appears in Table I (non-derivative) as a common stock sale; there are no derivative transactions reported in Table II.

Does the Form 4 indicate any plan-based (Rule 10b5-1) sale?

The form text does not include explicit mention of a 10b5-1 plan or deemed execution date; no plan-based designation is stated in the provided content.